Adolescent PCIP Randomized Feasibility Trial
Key facts
- Who runs it
- University of California, Los Angeles
- Where
- Los Angeles, United StatesSee the site
- Trial code
- Status
- Withdrawn
- Started
- 3 Jan 2022
- Ended
- 20 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Primary Care Intervention for PTSD (PCIP)
- Treatment As Usual
- Record updated
- 27 February 2026
- Why it stopped
- The study site preferred to conduct a non-randomized QI project
Who can take part
- Age
- 12 years to 22 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patient referred to the SHARK Program
- Patients must be at least 12 years old
- Screened for probable PTSD on UCLA RI, or at provider discretion of clinical relevancy
- If patient is under 18 years old, the patient's legal guardian is able and willing to provide informed consent for the patient to participate in the study
- Patient is able to complete study activities in English
Who cannot take part
- Suicidal ideation with a plan within the last two weeks or a suicide attempt within the past 30 days
- Inability to provide informed consent or assent, and/or complete procedures in English
Where in United States
- University of California, Los AngelesLos Angeles, United States
About the trial
What the trial wants to find out
There are three research questions: (1) whether the Primary Care Intervention for PTSD (PCIP) improves health outcomes; (2) whether and how the PCIP can be sustainably delivered via telehealth; and (3) how PCIP compares to treatment as usual (TAU) participants.
Read full original descriptionShow less
The mixed methods randomized feasibility trial of the protocol will be measured by the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance) (n=44 patients and their care givers). We will collect data on patient, caregiver, and clinic staff participation, retention, and satisfaction (Reach and Adoption), change in hypothesized treatment mechanisms and symptoms (Effectiveness), and facilitators and barriers to intervention delivery and fidelity (Implementation). We will,
1. Assess the reach and adoption of the protocol by analyzing quantitative data on patient and clinic staff participation, retention, and satisfaction; 2. Explore the effectiveness of the protocol through medical record review, quantitative assessments at baseline and post-treatment, and semi-structured qualitative interviews at baseline and post-treatment to: 3. Evaluate the implementation of the screening and intervention protocol with post-intervention semi-structured qualitative interviews to assess facilitators and barriers to intervention delivery, quantitative fidelity scales, observation of screening, and review of intervention audio recordings to assess fidelity to the protocol and intervention process.
The 2 groups in the trial
- BREATHE Primary Care Intervention for PTSD (PCIP)Treatment being tested
BREATHE PCIP is a treatment for Post-Traumatic Stress Disorder (PTSD) symptoms for use with individuals who have a diagnosis of PTSD or "probable PTSD." The treatment will be considered delivered when patients have learned and practiced breathing retraining and have discussed the symptoms of PTSD (Sessions 1 through 3).
Treatment: Primary Care Intervention for PTSD (PCIP)
- Treatment As UsualExisting treatment, for comparison
Receive standard care treatment and provided information on free or low cost mental health care referrals in the Los Angeles Area.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Adolescent BREATHE Primary Care Intervention for PTSD (PCIP) Randomized Feasibility Trial
- Record updated
- 27 February 2026